{
  "pmcid": "10638544",
  "sha256": "87932bb0987633c52454210aa778f15e5d4240e86e84f645e4a2a9422950b462",
  "timestamp_utc": "2025-11-09T23:08:16.858341+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 10.397372262773722,
    "reading_ease": 39.28882650196522,
    "word_count": 274
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Neuromuscular Electrical Stimulation for Intermittent Claudication: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Conducted in 11 UK hospitals, this multicentre, randomised controlled trial included patients with IC."
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted in 11 UK hospitals, this multicentre, randomised controlled trial included patients with IC."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised 1:1 to receive NMES plus local standard care or local standard care alone."
      },
      "Objective": {
        "score": 1,
        "evidence": "This trial evaluated the efficacy of neuromuscular electrical stimulation (NMES) as an adjunct to standard care in improving walking distances."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the change in absolute walking distance (AWD) at 3 months, assessed by a standardised treadmill test."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated with allocation concealment, and outcome assessors were blinded."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Randomisation was computer-generated with allocation concealment, and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Between February 2018 and March 2020, 200 participants were randomised; 100 to NMES and 100 to control."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Primary analysis included 160 participants (intention-to-treat)."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "NMES showed no significant improvement in AWD (0.83 units; 95% CI, âˆ’0.67 to 2.34; p = 0.28)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No device-related serious adverse events were reported, with 13 events in the NMES group and 16 in the control group, none related to the device."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: ISRCTN18242823."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Efficacy and Mechanism Evaluation Program, Medical Research Council, and National Institute for Health and Care Research."
      }
    },
    "total_score": 24,
    "max_score": 25
  }
}